Not every company is jumping onto the bandwagon and investing into weight loss drugs, however. One of the largest healthcare ...

Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The future of the weight loss market might not revolve around GLP-1 drugs.

MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 ...

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...

No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by ...

STAT reporters discuss investors' interest in autoimmune disease, GLP-1 supply issues, and big moments from #STATSummit.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...